Paper17510418
HIV protease inhibitors enhance the efficacy of irradiation.
Cuneo KC and 5 others. Cancer Res, 2007. Cited by 25 papers, by iCite.
Cite this record
ConductScience Library. HIV protease inhibitors enhance the efficacy of irradiation. Papers, record 17510418. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17510418
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Endothelial Cells | Major topic |
| HIV Protease Inhibitors | Major topic |
| Nelfinavir | Major topic |
| Radiation-Sensitizing Agents | Major topic |
| Apoptosis | |
| Cell Growth Processes | |
| Cell Movement | |
| Cells, Cultured | |
| Humans | |
| Signal Transduction |
Source PubMed
Grants8
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| P30 CA68485 | NCI NIH HHS | United States | P30CA068485 | PubMed and NIH | NIH RePORTER |
| P30 CA68485-08 | NCI NIH HHS | United States | P30CA684850 | PubMed | NIH RePORTER |
| P30-CA68485 | NCI NIH HHS | United States | P30CA068485 | PubMed and NIH | NIH RePORTER |
| P50-CA90949 | NCI NIH HHS | United States | P50CA090949 | PubMed and NIH | NIH RePORTER |
| R01-CA112385 | NCI NIH HHS | United States | R01CA112385 | PubMed and NIH | NIH RePORTER |
| R01-CA88076 | NCI NIH HHS | United States | R01CA088076 | PubMed and NIH | NIH RePORTER |
| R01-CA89674 | NCI NIH HHS | United States | R01CA089674 | PubMed and NIH | NIH RePORTER |
| U24 DK59637 | NIDDK NIH HHS | United States | U24DK059637 | PubMed and NIH | NIH RePORTER |
Cited by16
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 25 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40526256 | Machine learning-based identification of exosome-related biomarkers and drugs prediction in nasopharyngeal carcinoma. | Discov Oncol | 2025 | https://conductscience.org/library/papers/40526256 | PubMed |
| 38204254 | Novel Products as Promising Therapeutic Agents for Angiogenesis Inhibition. | Curr Drug Deliv | 2025 | https://conductscience.org/library/papers/38204254 | PubMed |
| 33803333 | Radiobiological Studies of Microvascular Damage through In Vitro Models: A Methodological Perspective. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/33803333 | PubMed |
| 33228205 | The Anti-Cancer Properties of the HIV Protease Inhibitor Nelfinavir. | Cancers (Basel) | 2020 | https://conductscience.org/library/papers/33228205 | PubMed |
| 32528888 | The Anti-Angiogenic Effects of Anti-Human Immunodeficiency Virus Drugs. | Front Oncol | 2020 | https://conductscience.org/library/papers/32528888 | PubMed |
| 27572820 | Pharmacological eEF2K activation promotes cell death and inhibits cancer progression. | EMBO Rep | 2016 | https://conductscience.org/library/papers/27572820 | PubMed |
| 27280849 | Oxidative Stress Mediates the Antiproliferative Effects of Nelfinavir in Breast Cancer Cells. | PLoS One | 2016 | https://conductscience.org/library/papers/27280849 | PubMed |
| 27121513 | Targeting the AKT pathway: Repositioning HIV protease inhibitors as radiosensitizers. | Indian J Med Res | 2016 | https://conductscience.org/library/papers/27121513 | PubMed |
| 26097685 | Nelfinavir and other protease inhibitors in cancer: mechanisms involved in anticancer activity. | F1000Res | 2015 | https://conductscience.org/library/papers/26097685 | PubMed |
| 24278747 | Endoplasmic reticulum stress: its role in disease and novel prospects for therapy. | Scientifica (Cairo) | 2012 | https://conductscience.org/library/papers/24278747 | PubMed |
| 22561027 | Kinomic profiling approach identifies Trk as a novel radiation modulator. | Radiother Oncol | 2012 | https://conductscience.org/library/papers/22561027 | PubMed |
| 21811091 | Nelfinavir induces radiation sensitization in pituitary adenoma cells. | Cancer Biol Ther | 2011 | https://conductscience.org/library/papers/21811091 | PubMed |
| 21414215 | Acute toxicity of second generation HIV protease-inhibitors in combination with radiotherapy: a retrospective case series. | Radiat Oncol | 2011 | https://conductscience.org/library/papers/21414215 | PubMed |
| 20515495 | Survival signalling and apoptosis resistance in glioblastomas: opportunities for targeted therapeutics. | Mol Cancer | 2010 | https://conductscience.org/library/papers/20515495 | PubMed |
| 19480971 | Radiation response in two HPV-infected head-and-neck cancer cell lines in comparison to a non-HPV-infected cell line and relationship to signaling through AKT. | Int J Radiat Oncol Biol Phys | 2009 | https://conductscience.org/library/papers/19480971 | PubMed |
| 19373040 | Repositioning HIV protease inhibitors as cancer therapeutics. | Curr Opin HIV AIDS | 2008 | https://conductscience.org/library/papers/19373040 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| AKT1 | 207 | PubTator's text mining | https://conductscience.org/library/genes/207 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/17510418
GET https://conductscience.org/api/papers/v1/17510418/authors